MedPath

Efficacy of Pediococcus acidilactoci K15 strain on allergic symptoms related to Japanese cedar pollinosis induced by artificial exposure

Phase 2
Conditions
Japanese cedar pollinosis
Registration Number
JPRN-jRCTs051190046
Lead Sponsor
Yamamoto Masashi
Brief Summary

In K-15 lactic acid bacteria group, improvement of symptoms (especially nasal symptoms) was observed. There was no problem with safety and the continuity was godd.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

1.individuals aged from 20 to 64 who will give informed consent upon their will
2.individuals who had allergic symptoms such as sneezing, rhinorrhea, nasal obstruction and eye itching during Japanese cedar pollen dispersal season in the past two consecutive years
3.individuals who show positive IgE titer more than class II for Japanese cedar pollen by RAST

Exclusion Criteria

1.individuals receiving allergen (Japanese cedar pollen) immunotherapy or those who will receive allergen immunotherapy during the study
2.individuals with active diseases and judged to be inappropriate to join the study by their primary care physicians
3.individuals who are pregnant and brest-feeding or will have a plan of pregnancy during the study
4.individuals who habitually intake prebiotics or probiotics (more than 3 days in a week)
5.individuals who join other clinical studies
6.individuals who take anti-allergic drugs before or during the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total nasal symptom score (Severity of allergic symptoms induced by artificial Japanese cedar dispersal evaluated by scoring system), VAS score of symptomatic severity
Secondary Outcome Measures
NameTimeMethod
Severity of rhinitis, Severity of conjunctivitis, objective nasal mucosal findings, amounts of nasal discharge
© Copyright 2025. All Rights Reserved by MedPath